Rosiglitazone increases the expression of peroxisome proliferator-activated receptor-γ target genes in adipose tissue, liver, and skeletal muscle in the sheep fetus in late gestation

Endocrinology

Volumn 150, Issue 9, 2009, Pages 4287-4294

  Muhlhausler, Beverly S ^a   Morrison, J L ^a   McMillen, I C ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; FATTY ACID; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; INSULIN; LEPTIN; LIPOPROTEIN LIPASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); ROSIGLITAZONE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL GAS; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; FETUS LIVER; FETUS WEIGHT; GENE EXPRESSION; GENE TARGETING; INSULIN BLOOD LEVEL; NONHUMAN; NUCLEOTIDE SEQUENCE; OSMOTIC PUMP; OVERNUTRITION; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SHEEP; SKELETAL MUSCLE; THIRD TRIMESTER PREGNANCY; UPREGULATION;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; FEMALE; FETUS; GLYCEROL-3-PHOSPHATE DEHYDROGENASE (NAD+); INSULIN; LEPTIN; LIPOPROTEIN LIPASE; LIVER; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MUSCLE, SKELETAL; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PPAR ALPHA; PPAR GAMMA; PREGNANCY; PREGNANCY, ANIMAL; RNA, MESSENGER; SHEEP; THIAZOLIDINEDIONES; TRANS-ACTIVATORS;

EID: 69249090213     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0462     Document Type: Article

References (40)

1. Cetin I, Morpurgo PS, Radaelli T, Taricco E, Cortelazzi D, Bellotti M, Pardi G, Beck-Peccoz P 2000 Fetal plasma leptin concentrations: relationship with different fetal growth patterns from 19 weeks up to term. Pediatr Res 48:646-651
2. Tapanainen P, Leinonen E, Ruokonen A, Knip M 2001 Leptin concentrations are elevated in newborn infants of diabetic mothers. Hormone Res 55:185-190
3. Silverman BL, Rizzo TA, Cho NH, Metzger BE 1998 Long-term effects of the intrauterine environment. Diabetes Care 21:B142-B149
4. Plagemann A, Harder T, Kohlhoff R, Rhode W, Dörner G 1997 Overweight and obesity in infants of mothers with long-term insulin-dependent diabetes or gestational diabetes. Int J Obes Relat Metab Disord 21:451-456
5. Plagemann A, Harder T, Rake A, Waas T, Melchior K, Ziska T, Rohde W, Dörner G 1999 Observations on the orexigenic hypothalamic neuropeptide Y-system in neonatally overfed weanling rats. J Neuroendocrinol 11:541-546
6. Martin RJ, Hausman GJ, Hausman DB 1998 Regulation of adipose cell development in utero. Proc Soc Exp Biol Metab 219:200-210
7. Hauner H 2002 The mode of action of thiazolidinediones. Diabetes Metab Res Rev 18:S10-S15
8. Quinn CE, Hamilton PK, Lockhart CJ, McVeigh GE 2008 Thiazolidinediones: effects on insulin resistance and the cardiovascular system. Br J Pharmacol 153:636-645
9. Kintscher U, Law RE 2005 PPARγ-mediated insulin sensitization: the importance of fat versus muscle. Am J Physiol Endocrinol Metab 288:E287-E291
10. Kadowaki T, Yamauchi T 2005 Adiponectin and adiponectin receptors. Endocr Rev 26:439-451
11. Sheng T, Yang K 2008 Adiponectin and its association with insulin resistance and type 2 diabetes. J Genet Genomics 35:321-326
12. Muhlhausler BS, Duffield JA, McMillen IC 2007 Increased maternal nutrition stimulates peroxisome proliferator activated receptor-γ (PPARγ), adiponectin and leptin mRNA expression in adipose tissue before birth. Endocrinology 148:878-885
13. Muhlhausler BS, Adam CL, Findlay PA, Duffield JA, McMillen IC 2006 Increased maternal nutrition alters development of the appetite-regulating network in the brain. FASEB J 20:1257-1259
14. Mühlhäusler BS, Roberts CT, McFarlane JR, Kauter KG, McMillen IC 2002 Fetal leptin is a signal of fat mass independent of maternal nutrition in ewes fed at or above maintenance energy requirements. Biol Reprod 67:493-499
15. Edwards LJ, Simonetta G, Owens JA, Robinson JS, McMillen IC 1999 Restriction of placental and fetal growth in sheep alters fetal blood pressure responses to angiotensin II and captopril. J Physiol 515:897-904
16. Danielson L, McMillen IC, Dyer JL, Morrison JL 2005 Restriction of placental growth results in greater hypotensive response to α-adrenergic blockade in fetal sheep during late gestation. J Physiol 563:611-620
17. Aldermann GA, Morgan DE, Harvard A, Edwards RE, Todd JR 1975 Energy allowances and feeding systems for ruminants. In: Ministry of Agriculture, Fisheries and Food: Technical Bulletin 33. London: Her Majesty's Stationery Office
18. Mühlhäusler BS, Roberts CT, Yuen BS, Marrocco E, Budge H, Symonds ME, McFarlane JR, Kauter KG, Stagg P, Pearse JK, McMillen IC 2003 Determinants of fetal leptin synthesis, fat mass, and circulating leptin concentrations in well-nourished ewes in late pregnancy. Endocrinology 144:4947-4954
19. Yuen BS, Owens PC, Muhlhausler BS, Roberts CT, Symonds ME, Keisler DH, McFarlane JR, Kauter K, Evens Y, McMillen IC 2003 Leptin alters the structural and functional characteristics of adipose tissue before birth. FASEB J 17:1102-1104
20. Ullrich NF, Purnell JQ, Brunzell JD 2001 Adipose tissue fatty acid composition in humans with lipoprotein lipase deficiency. J Invest Med 49:273-275
21. Takasawa K, Kubota N, Terauchi Y, Kadowaki T 2008 Impact of increased PPARγ activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment. Endocr J 55:767-776
22. Philp LK, Muhlhausler BS, Janovska A, Wittert GA, Duffield JA, McMillen IC 2008 Maternal overnutrition suppresses the phosphorylation of 5′-AMP-activated protein kinase in liver, but not skeletal muscle, in the fetal and neonatal sheep. Am J Physiol Regul Integr Comp Physiol 295:R1982-R1990
23. Nawrocki AR, Rajala MW, Tomas E, Pajvani UB, Saha AK, Trumbauer ME, Pang Z, Chen AS, Ruderman NB, Chen H, Rossetti L, Scherer PE 2006 Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor γ agonists. J Biol Chem 281:2654-2660
24. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G 2003 Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression. Diabetes 52:1779-1785
25. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B 2004 Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 219:9-15
26. Ladu MJ, Kapsas H, Palmer WK 1991 Regulation of lipoprotein lipase in adipose and muscle tissues during fasting. Am J Physiol Regul Integr Comp Physiol 260:R953-R959
27. Yuen BS, Owens PC, McFarlane JR, Symonds ME, Kauter K, Edwards LJ, Kauter KG, McMillen IC 2002 Circulating leptin concentrations are positively related to leptin messenger RNA expression in the adipose tissue of fetal sheep in the pregnant ewe fed at or below maintenance energy requirements during late gestation. Biol Reprod 67:911-916
28. Muhlhausler BS, Duffield JA, McMillen IC 2007 Increased maternal nutrition increases leptin expression in perirenal and subcutaneous adipose tissue in the postnatal lamb. Endocrinology 148:6157-6163
29. Rabe K, Lehrke M, Parhofer KG, Broedl UC 2008 Adipokines and insulin resistance. Mol Med 14:741-751
30. Fowden AL, Mundy L, Silver M 1998 Developmental regulation of gluconeogenesis in the sheep fetus during late gestation. J Physiol 508:937-947
31. Natali A, Ferrannini E 2006 Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review. Diabetologia 49:434-441
32. Finck BN, Kelly DP 2006 PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 116:615-622
33. Al-Khalili L, Forsgren M, Kannisto K, Zierath JR, Lönnqvist F, Krook A 2005 Enhanced insulin-stimulated glycogen synthesis in response to insulin, metformin or rosiglitazone is associated with increased mRNA expression of GLUT4 and peroxisomal proliferator activator receptor γ co-activator 1. Diabetologia 48:1173-1179
34. Feinstein DL, Spagnolo A, Akar C, Weinberg G, Murphy P, Gavrilyuk V, Dello Russo C 2005 Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key? Biochem Pharmacol 70:177-188
35. Fowden A 1995 Nutrient requirements for normal fetal growth and metabolism. In: Hanson M, Spencer J, Rodeck C, eds. Fetus and neonate: physiology and clinical applications. 1st ed. Cambridge, UK: Cambridge University Press; 31-56
36. Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA 2007 Thiazolidinediones improve β-cell function in type 2 diabetic patients. Am J Physiol Endocrinol Metab 292:E871-E883
37. Chiarelli F, Di Marzio D 2008 Peroxisome proliferator-activated receptor-γ agonists and diabetes: current evidence and future perspectives. Vasc Health Risk Manag 4:297-304
38. Hay Jr WW 1994 Placental transport of nutrients to the fetus. Horm Res 42:215-222
39. Hay WW, Sparks JW, Wilkening RB, Battaglia FC, Giacomo M 1984 Fetal glucose uptake and utilisation as functions of maternal glucose concentrations. Am J Physiol Endocrinol Metab 246:E237-E242
40. Proud CG 2006 Regulation of protein synthesis by insulin. Biochem Soc Trans 34:213-216